Tanimswiss Pharma Launches Comprehensive RLD Sourcing Service to Support Global Pharmaceutical Development
Basel, Switzerland – Tanimswiss Pharma GmbH today announced the expansion of its RLD (Reference Listed Drug) sourcing capabilities, offering pharmaceutical companies a streamlined solution for procuring authentic comparator drugs across the United States, European Union, and other global markets. The new service aims to simplify one of the most critical yet complex aspects of generic drug development and bioequivalence studies.

A Solution to a Growing Industry Challenge
Reference Listed Drugs remain essential for pharmaceutical development, serving as the benchmark for bioequivalence studies, clinical trials, and regulatory submissions. However, sourcing authentic RLDs presents significant compliance, regulatory, and logistical challenges. With increasing market complexities and stricter regulatory oversight, companies require a trusted partner capable of managing these challenges efficiently.

"Sourcing RLDs is far more than procurement—it's about regulatory integrity, product authenticity, and operational precision," said a spokesperson for Tanimswiss Pharma. "Many pharmaceutical companies struggle with chain-of-custody documentation, temperature-controlled logistics, and regulatory compliance across multiple jurisdictions. Our expanded RLD sourcing service addresses these pain points directly."

What Sets Tanimswiss Pharma Apart
Tanimswiss Pharma's RLD sourcing offering combines regulatory expertise with operational excellence:

Full Traceability & Documentation: Complete chain-of-custody documentation, anti-counterfeiting measures, and regulatory packets prepared for clinical, bioequivalence, and regulatory programs.

Compliance-First Approach: GDP (Good Distribution Practice) licensing, temperature-controlled shipping and storage, and authenticity verification across all sourcing activities.

Global Market Access: Direct access to FDA-approved reference listed drugs from the United States, EMA-authorized medicinal products from the European Union, and validated reference products from rest-of-world markets.

Regulatory Expertise: Comprehensive regulatory documentation packages, including Certificates of Analysis (CoA), Certificates of Custody (CoC), and import permits tailored to specific market requirements.

Supporting the Full Pharmaceutical Lifecycle
This service represents one component of Tanimswiss Pharma's integrated approach to pharmaceutical development. The company combines RLD sourcing with technology transfer services and strategic partnership models to move products from concept through commercialization.

"Our philosophy is simple: accelerate progress across the healthcare value chain," the spokesperson continued. "Whether a company needs a single batch of comparators for an immediate study or coordinated sourcing across multiple markets for global regulatory submissions, we provide the expertise and infrastructure to execute flawlessly."

Why Compliance Matters in RLD Sourcing
The pharmaceutical industry faces escalating risks related to counterfeit products, supply chain disruptions, and regulatory misalignment. By partnering with a GDP-compliant sourcing partner, companies mitigate these risks while building the regulatory confidence necessary for successful product approvals.

Tanimswiss Pharma's RLD sourcing service ensures that every product meets the highest standards for quality, authenticity, and documentation—critical requirements for regulatory agencies such as the FDA and EMA.

Expanding Pharmaceutical Solutions
This RLD sourcing launch complements Tanimswiss Pharma's existing capabilities in technology transfer and strategic partnerships. Together, these services create a comprehensive framework for companies seeking to develop, commercialize, and manage pharmaceutical products in a compliant and efficient manner.

About Tanimswiss Pharma
Tanimswiss Pharma GmbH is a pharmaceutical solutions provider specializing in RLD sourcing, technology transfer, and strategic partnerships. Based in Basel, Switzerland, the company supports generic drug developers, innovators, and contract research organizations across the healthcare value chain. From regulatory strategy to supply chain execution, Tanimswiss Pharma combines scientific rigor with commercial acumen to accelerate pharmaceutical development and market access.

Contact Information
Tanimswiss Pharma GmbH
Sandgrubenstrasse 44
4058 Basel, Switzerland

📧 Email: [email protected]
📱 Phone: +41 77 943 8627
🌐 Website: www.tanimpharma.com
For inquiries regarding RLD sourcing services, technology transfer, or strategic partnerships, please contact the team directly.